Lam Research (LRCX) shares sank 10% after the tech giant flagged supply-chain constraints and guided to lower China sales, taking the shine off its fiscal Q1 earnings and revenue beats reported overnight.
Intraday trading volume climbed to over 12.7 million from a daily average of roughly 9.33 million.
NVE (NVEC) shares slumped 33% amid heavy trading after the company reported lower fiscal Q2 net income and revenue.
Intraday trading volume rose to over 307,000 from a daily average of about 146,000.
Wedbush Securities adjusted its price target for Avalo Therapeutics (AVTX) to $22 from $34, while maintaining its outperform rating.
Shares plunged 35% as intraday trading volume surged to over 17.3 million from a daily average of about 972,000.
Price: 231.81, Change: -29.00, Percent Change: -11.12
Comments